Detalles de la búsqueda
1.
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary.
Endocr Pract
; 26(10): 1196-1224, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33471721
2.
American Association of Clinical Endocrinologists/American College of Endocrinology Management of Dyslipidemia and Prevention of Cardiovascular Disease Clinical Practice Guidelines.
Diabetes Spectr
; 31(3): 234-245, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30140139
3.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
Endocr Pract
; 23(Suppl 2): 1-87, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28437620
4.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARYComplete Appendix to Guidelines available at http://journals.aace.com.
Endocr Pract
; 23(4): 479-497, 2017 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28156151
5.
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2015 EXECUTIVE SUMMARY.
Endocr Pract
; 21(12): 1403-14, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26642101
6.
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2020 EXECUTIVE SUMMARY.
Endocr Pract
; 26(1): 107-139, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32022600
7.
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2019 EXECUTIVE SUMMARY.
Endocr Pract
; 25(1): 69-100, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30742570
8.
DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases.
Metabolism
; : 155931, 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38852020
9.
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY.
Endocr Pract
; 24(1): 91-120, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29368965
10.
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY.
Endocr Pract
; 23(2): 207-238, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28095040
11.
DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases.
J Diabetes Complications
; 36(2): 108101, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34922811
12.
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY.
Endocr Pract
; 22(1): 84-113, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26731084
13.
AACE/ACE comprehensive diabetes management algorithm 2015.
Endocr Pract
; 21(4): 438-47, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25877012
14.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY--CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN--2015--EXECUTIVE SUMMARY.
Endocr Pract
; 21(4): 413-37, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27408942
15.
American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015.
Endocr Pract
; 21 Suppl 1: 1-87, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25869408
16.
Oral pharmacologic treatment of type 2 diabetes mellitus.
Ann Intern Med
; 157(1): 75-6; author reply 76-7, 2012 Jul 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-22751768
17.
Metabolic consequences of hyperglycemia and insulin resistance.
Clin Cornerstone
; 8 Suppl 7: S30-42, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-18154189
18.
Obviating much of the need for insulin therapy in type 2 diabetes mellitus: A re-assessment of insulin therapy's safety profile.
Postgrad Med
; 128(6): 609-19, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27210018
19.
Adding noninsulin antidiabetic drugs to metformin therapy for type 2 diabetes.
JAMA
; 304(4): 405-6; author reply 406-7, 2010 Jul 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-20664035
20.
Impact of new lipid management guidelines on the treatment of extreme and very high-risk patients: AACE/ACE and AHA/ACC guidelines.
J Diabetes
; 12(2): 105-109, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31777166